Skip to main content
. 2011 Sep 8;52(10):7122–7133. doi: 10.1167/iovs.10-5606

Table 4.

CNVs of High Interest

Gene Name Cytoband Approximate Size (kb) Type Individuals (n) Novel to DGV Validation Method Gene Function
NT5C1B 2p24.2 144 Deletion 2 No qPCR Cytosolic 5′ nucleotidase
IMMT 2p11.2 217 Duplication 2 No qPCR Mitochondrial inner membrane protein
NPHP1 2q13 147 Duplication 2 No qPCR Control of cell division, cell–cell and cell-matrix adhesion
No RefSeq genes 5p15.33 60 Duplication 4 Yes qPCR N/A
DMXL1, DTWD2 5p23.1 776 Both 2 Yes qPCR DMXL1-WD domain containing; DTWD2 - no known function
CD5, CD6 11q12.2 145 Duplication 2 Yes qPCR Glycoproteins involved in T-cell activation
C12orf56, TBK1, XPOT, RASSF3 12q14.2 486 Duplication 2 Yes aCGH C12orf56, hypothetical protein; XPOT, tRNA exportin TBK1, Mediates NFKB activation RASSF3, Ras association domain containing protein
TULP3 12p13.33 20 Deletion 5 Yes qPCR Retina expressed transcription factor
FAM27L 17p11.2 482 Duplication 4 No qPCR No known function
No RefSeq genes 18p11.32 89 Deletion 3 No qPCR N/A
PAK7 20p12 144 Duplication 2 Yes aCHG Brain-expressed kinase involved in neurite growth

Included are genes in CNV region, cytoband location, approximate size averaged across multiple programs and individuals, CNV type and the number of individuals with the given CNV, the presence or absence of the CNV in the database of genomic variants (Iafrate et al., 2004), method of validation (qPCR or aCGH), and the gene function. Exact breakpoints determined by each program in each individual are available in Supplementary Table S1 (http://www.iovs.org/lookup/suppl/doi:10.1167/iovs.10–5606-/DCSupplemental).